---
title: "CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial  | CERO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282689435.md"
description: "CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News"
datetime: "2026-04-14T04:15:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282689435.md)
  - [en](https://longbridge.com/en/news/282689435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282689435.md)
---

# CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial  | CERO Stock News

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News

### Related Stocks

- [CERO.US](https://longbridge.com/en/quote/CERO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [CEROW.US](https://longbridge.com/en/quote/CEROW.US.md)

## Related News & Research

- [CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial  | CERO Stock News](https://longbridge.com/en/news/285939883.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [IT Sector Accounts for Nearly One Third of U.S. Securities Litigation Risk in 1H 2026](https://longbridge.com/en/news/294507902.md)
- [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)